baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

ALKERMES PLC DL-,01/ IE00B56GVS15 /

2024-05-10 9:24:31 AM	Chg. +0.2000	Volume	Bid9:51:21 PM	Ask9:51:21 PM	Market Capitalization	Dividend Y.	P/E Ratio
22.2000EUR	+0.91%	0 Turnover: 0.0000	-Bid Size: -	-Ask Size: -	3.78 bill.EUR	-	-

GlobeNewswire 03-26 Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Up...

GlobeNewswire 03-06 Zenas BioPharma Appoints Patricia Allen to its Board of Directors

GlobeNewswire 01-18 SediVision Wastewater Technology Announces New Company Vice President

GlobeNewswire 01-08 Mural Oncology Announces Enhancements to Late-Stage Clinical Trials

GlobeNewswire 2023-12-04 Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director

GlobeNewswire 2023-11-15 Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies

GlobeNewswire 2023-09-26 OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board

GlobeNewswire 2023-09-11 Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors

GlobeNewswire 2023-08-29 Arbor Biotechnologies Appoints Ajim Tamboli as Chief Financial Officer

GlobeNewswire 2022-03-28 Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business...

GlobeNewswire 2022-03-16 Baudax Bio Reports 2021 Fourth Quarter and Annual Financial Results

Newsfile Corp 2022-03-15 Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development

GlobeNewswire 2022-03-15 Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire 2022-03-08 Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surg...

GlobeNewswire 2022-03-02 Baudax Bio Announces Seventh Orange Book Listable Patent for ANJESO®

GlobeNewswire 2022-02-10 Finch Therapeutics Announces Additions to Senior Leadership Team

GlobeNewswire 2022-01-24 Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates

GlobeNewswire 2021-12-06 AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors

GlobeNewswire 2021-11-22 Zai Lab Appoints Richard Gaynor, MD, to its Board of Directors

GlobeNewswire 2021-11-04 Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights

GlobeNewswire 2021-09-08 Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer

GlobeNewswire 2021-08-05 Baudax Bio Reports Second Quarter 2021 Financial Results and Highlights

GlobeNewswire 2021-06-22 BioCorRx Welcomes Four Experts to Expanded Scientific Advisory Board

GlobeNewswire 2021-06-08 Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on th...

GlobeNewswire 2021-05-17 Baudax Bio Announces Publication of Phase IIIb ANJESO® Data in the Journal Pain Management

ALKERMES PLC DL-,01/ IE00B56GVS15 /

If you wish to receive reply to your feedback, please provide your email address.